Skip to content

AGEPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AGEPHAR

BE 1002.549.933
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€387
2024 · €2,379-€1,992
Equity
€22,766
2024 · €22,379+€387
Cash
€29,276
2024 · €38,126-€8,849
Balance sheet total
€440,640
2024 · €468,461-€27,821

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€26,200

    down €26,200 (-11.2%), from €233,617 to €207,417

  • Receivables within one year +€16,959

    up €16,959 (+50.8%), from €33,367 to €50,326

  • Tangible fixed assets -€16,500

    down €16,500 (-31.7%), from €52,125 to €35,625

  • Cash -€8,849

    down €8,849 (-23.2%), from €38,126 to €29,276

    mainly Debts after one year (-€29,058) and Receivables within one year (-€16,959)

Equity and liabilities
  • Debts after one year -€29,058

    down €29,058 (-10.5%), from €278,010 to €248,952

  • Trade debts +€14,215

    up €14,215 (+41.3%), from €34,380 to €48,595

  • Other debts -€13,917

    down €13,917 (-20.0%), from €69,606 to €55,689

Income statement
  • Gross operating margin -€25,340

    down €25,340 (-18.0%), from €141,002 to €115,662

  • Staff costs -€13,598

    down €13,598 (-20.4%), from €66,589 to €52,991

  • Depreciation -€3,558

    down €3,558 (-7.7%), from €46,258 to €42,700

  • Financial charges -€3,418

    down €3,418 (-15.5%), from €22,042 to €18,624

  • Other operating charges -€2,762

    down €2,762 (-77.2%), from €3,579 to €817

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €2,379
Gross operating margin -€25,340
Staff costs +€13,598
Depreciation +€3,558
Other operating charges +€2,762
Financial charges +€3,418
Taxes +€12
Result 2025 €387

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€18,811
Investment €0
Financing -€27,660
Cash 2024 €38,126
Net result for the year +€387
Depreciation +€42,700
Stocks and contracts -€3,205
Receivables within one year -€16,959
Deferred charges and accrued income -€3,564
Trade debts +€14,215
Tax, wage and social debts -€1,097
Other debts -€13,917
Accrued charges and deferred income +€251
Debts after one year -€29,058
Current portion of long-term debt +€1,398
Cash 2025 €29,276
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €468,461 €440,640 -€27,821 -5.9%
Fixed assets 21/28 €285,742 €243,042 -€42,700 -14.9%
Intangible fixed assets 21 €233,617 €207,417 -€26,200 -11.2%
Tangible fixed assets 22/27 €52,125 €35,625 -€16,500 -31.7%
Furniture and vehicles 24 €52,125 €35,625 -€16,500 -31.7%
Current assets 29/58 €182,719 €197,598 +€14,879 +8.1%
Stocks and contracts in progress 3 €106,069 €109,274 +€3,205 +3.0%
Stocks 30/36 €106,069 €109,274 +€3,205 +3.0%
Amounts receivable within one year 40/41 €33,367 €50,326 +€16,959 +50.8%
Trade receivables 40 €33,367 €50,326 +€16,959 +50.8%
Cash at bank and in hand 54/58 €38,126 €29,276 -€8,849 -23.2%
Deferred charges and accrued income 490/1 €5,158 €8,722 +€3,564 +69.1%
Total equity and liabilities 10/49 €468,461 €440,640 -€27,821 -5.9%
Equity 10/15 €22,379 €22,766 +€387 +1.7%
Contributions 10/11 €20,000 €20,000 = 0.0%
Profit (loss) carried forward 14 €2,379 €2,766 +€387 +16.3%
Amounts payable 17/49 €446,082 €417,874 -€28,208 -6.3%
Amounts payable after more than one year 17 €278,010 €248,952 -€29,058 -10.5%
Financial debts 170/4 €278,010 €248,952 -€29,058 -10.5%
Amounts payable within one year 42/48 €158,688 €159,287 +€599 +0.4%
Current portion of amounts payable after more than one year 42 €27,660 €29,058 +€1,398 +5.1%
Trade debts 44 €34,380 €48,595 +€14,215 +41.3%
Suppliers 440/4 €34,380 €48,595 +€14,215 +41.3%
Taxes, remuneration and social security 45 €27,041 €25,945 -€1,097 -4.1%
Taxes 450/3 €4,477 €7,150 +€2,673 +59.7%
Remuneration and social security 454/9 €22,565 €18,795 -€3,770 -16.7%
Other amounts payable 47/48 €69,606 €55,689 -€13,917 -20.0%
Accrued charges and deferred income 492/3 €9,385 €9,636 +€251 +2.7%
Remuneration, social security and pensions 62 €66,589 €52,991 -€13,598 -20.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €46,258 €42,700 -€3,558 -7.7%
Other operating charges 640/8 €3,579 €817 -€2,762 -77.2%
Gross operating margin 9900 €141,002 €115,662 -€25,340 -18.0%
Operating profit (loss) 9901 €24,575 €19,153 -€5,422 -22.1%
Financial charges 65/66B €22,042 €18,624 -€3,418 -15.5%
Recurring financial charges 65 €22,042 €18,624 -€3,418 -15.5%
Profit (loss) for the period before taxes 9903 €2,533 €529 -€2,004 -79.1%
Income taxes 67/77 €154 €142 -€12 -7.8%
Profit (loss) for the period 9904 €2,379 €387 -€1,992 -83.7%
Profit (loss) for the period to be appropriated 9905 €2,379 €387 -€1,992 -83.7%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.